Phibro Animal Health
Phibro Animal Health is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware. History. The company was founded in 1946 as Phillip Brothers Chemicals, Inc. In 1974, it acquired Koffolk, an animal nutrition company based in Israel. In 2000, Pfizer  sold its medicated feed additives business to Phibro Animal Health In 2003, the company changed its name from Phillip Brothers Chemicals to Phibro Animal Health. In 2009, the company acquired Baltzell US mineral nutrition business and ABIC Laboratories, a vaccine maker from Israel. In 2014, Phibro Animal Health held an initial public offering and became listed on the Nasdaq. In 2018, the company established a biotech facility in Sligo, Ireland producing animal health vaccines. It became the company's first manufacturing plant in Europe. Controversy. During the 2022 Russian invasion of Ukraine, Phibro Animal Health refused to join the international  community and withdraw from the Russian market. Research from Yale University updated on April 28, 2022 identifying how companies were reacting to Russia's invasion identified Phibro Animal Health in the worst category of "Digging In", meaning Defying Demands for Exit: companies defying demands for exit/reduction of activities.